As of the latest SEC filings, enGene Therapeutics Inc. (ENGNW) is held by 2 institutional funds. The largest fund shareholder is Saba Capital Income & Opportunities Fund (BRW), holding an estimated $2,230.00 in market value, representing a significant portion of its portfolio.
Funds holding enGene Therapeutics Inc. (ENGNW)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- ENGNW
- CIK:
- 0001980845
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
BRW
Saba Capital Income & Opportunities Fund
|
CEF | Independent / Boutique | 0.00% | $2,230.00 | 1,115 | Apr 30, 2026 | Jun 26, 2026 |
|
BRW
Saba Capital Income & Opportunities Fund
|
CEF | Independent / Boutique | 0.00% | -$2,230.00 | -1,115 | Apr 30, 2026 | Jun 26, 2026 |
Advertisement (320x50)